Stefano M Bertozzi

Author PubWeight™ 73.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009 8.99
2 HIV prevention transformed: the new prevention research agenda. Lancet 2011 4.23
3 High risk of HIV in non-brothel based female sex workers in India. BMC Public Health 2005 3.58
4 Sex behaviour of men who have sex with men and risk of HIV in Andhra Pradesh, India. AIDS 2005 3.35
5 Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost? Lancet 2004 3.14
6 Estimated numbers of men and women infected with HIV/AIDS in Tijuana, Mexico. J Urban Health 2006 3.04
7 Economic impact of antiretroviral therapy prescription decisions in the context of rapid scaling-up of access to treatment: lessons from Mexico. AIDS 2006 2.87
8 HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries. BMC Health Serv Res 2007 2.55
9 Current priorities in health research funding and lack of impact on the number of child deaths per year. Am J Public Health 2006 2.44
10 Combination HIV prevention. Lancet 2008 2.10
11 Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework. AIDS 2008 1.87
12 Demography and sex work characteristics of female sex workers in India. BMC Int Health Hum Rights 2006 1.76
13 HIV prevention cost-effectiveness: a systematic review. BMC Public Health 2009 1.58
14 How the Avahan HIV prevention program transitioned from the Gates Foundation to the government of India. Health Aff (Millwood) 2013 1.50
15 Emergency contraception use is correlated with increased condom use among adolescents: results from Mexico. J Adolesc Health 2004 1.33
16 Evaluation of large-scale combination HIV prevention programs: essential issues. J Acquir Immune Defic Syndr 2011 1.32
17 Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study. PLoS One 2009 1.24
18 The costs, benefits, and cost-effectiveness of interventions to reduce maternal morbidity and mortality in Mexico. PLoS One 2007 1.18
19 Variations in prenatal care quality for the rural poor in Mexico. Health Aff (Millwood) 2007 1.17
20 Community-based prevention leads to an increase in condom use and a reduction in sexually transmitted infections (STIs) among men who have sex with men (MSM) and female sex workers (FSW): the Frontiers Prevention Project (FPP) evaluation results. BMC Public Health 2010 1.15
21 Risk behaviors of 15-21 year olds in Mexico lead to a high prevalence of sexually transmitted infections: results of a survey in disadvantaged urban areas. BMC Public Health 2006 1.13
22 HIV prevention in Mexican schools: prospective randomised evaluation of intervention. BMJ 2006 1.09
23 Forecast of demand for antiretroviral drugs in low and middle-income countries: 2007-2008. AIDS 2007 1.09
24 Costing of scaling up HIV/AIDS treatment in Mexico. Salud Publica Mex 2008 1.02
25 How much attention is needed towards men who sell sex to men for HIV prevention in India? BMC Public Health 2006 1.02
26 HIV testing among female sex workers in Andhra Pradesh, India. AIDS 2005 1.01
27 Correlates of condom use in a sample of MSM in Ecuador. BMC Public Health 2006 0.99
28 Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico. BMC Infect Dis 2008 0.96
29 High prevalence of obesity among the poor in Mexico. JAMA 2004 0.95
30 Willingness-to-accept reductions in HIV risks: conditional economic incentives in Mexico. Eur J Health Econ 2013 0.95
31 Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks. Am J Trop Med Hyg 2008 0.91
32 Evaluation of HIV prevention programmes: the case of Avahan. Sex Transm Infect 2010 0.89
33 Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting. Health Policy Plan 2003 0.88
34 Optimizing HIV treatment programs. Curr Opin HIV AIDS 2010 0.87
35 Access to condoms for female sex workers in Andhra Pradesh. Natl Med J India 2007 0.86
36 Cost of AIDS care in Mexico: what are its main individual predictors? Arch Med Res 2005 0.84
37 Can cost studies improve the performance of donor-financed HIV treatment? AIDS 2011 0.81
38 Herpes simplex virus type 2 among Mexican high school adolescents: prevalence and association with community characteristics. Arch Med Res 2007 0.80
39 [A novel school-based strategy for the prevention of HIV/AIDS, sexually transmitted disease (STDs), and teen pregnancies]. Salud Publica Mex 2006 0.80
40 [Facing the HIV/AIDS epidemic in Mexico: the response of the health sector]. Rev Invest Clin 2004 0.79
41 The economic impacts of HIV/AIDS on households and economies. AIDS 2008 0.79
42 Improving enrollment and utilization of the Oportunidades program in Mexico could increase its effectiveness. J Nutr 2008 0.79
43 Stakeholders' opinions and expectations of the Global Fund and their potential economic implications. AIDS 2008 0.78
44 A predictive model for the utilization of curative ambulatory health services in Mexico. Salud Publica Mex 2008 0.78
45 [Influenza vaccination in the elderly population in Mexico: economic considerations]. Salud Publica Mex 2005 0.76
46 Improving access to treatment for HIV in sub-Saharan Africa. BMJ 2010 0.75
47 Scaling up HAART in Mexico. Response to Volkow et al. AIDS 2007 0.75
48 Informing scale-up and resource allocation: the use of economic analysis. AIDS 2008 0.75
49 [The health gap in Mexico, measured through child mortality]. Salud Publica Mex 2003 0.75
50 [Mixed design for the evaluation of the Mesoamerica Health 2015 initiative]. Salud Publica Mex 2011 0.75
51 Post-emergency: providing effective, sustainable, life-long care to everyone with AIDS. Indian J Med Res 2006 0.75
52 [Cost-effectiveness of breast cancer screening policies in Mexico]. Salud Publica Mex 2009 0.75
53 Re: This special issue of AIDS--a mix of recent economic analyses and commentary on how best to distill economic insights to improve HIV/AIDS policies and programmes. AIDS 2008 0.75
54 Combining evidence for access to and benefits from antiretroviral treatment to inform planning. AIDS 2008 0.75